Efficacy and safety of alfimeprase in patients with acute peripheral arterial occlusion (PAO)
To access this article, please choose from the options below
Competition of interest: Mr Joing was an employee of ARCA biopharma, Inc (formerly named Nuvelo, Inc) at the time of the study.
The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.
PII: S0741-5214(09)01698-X
doi:10.1016/j.jvs.2009.08.053
© 2010 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
